Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Pediatrics|January 19, 2008
How effectively can health care settings beyond the traditional medical home provide vaccines to adolescents?Stanley J Schaffer, John Fontanesi, Donna Rickert, et al.
Journal of the American Pharmacists Association : Japha|March 3, 2024
Pharmacist assessments and care to improve adult vaccination rates: A report from project IMPACT vaccine confidenceBenjamin M Bluml, Scott A Hamstra, Lisa L Tonrey, et al.
Human Vaccines|August 24, 2011
Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adultsDaniel M Musher, Susan B Manoff, Richard D McFetridge, et al.
Journal of Occupational and Environmental Medicine|March 29, 2003
Analysis of adverse events after anthrax immunization in US Army medical personnelGlenn M Wasserman, John D Grabenstein, Phillip R Pittman, et al.
Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science|September 27, 2005
Use of an electronic monitoring system for self-reporting smallpox vaccine reactionsStuart S Olmsted, John D Grabenstein, Arvind K Jain, et al.
The Journal of Infectious Diseases|January 22, 2010
Revaccination with a 23-valent pneumococcal polysaccharide vaccine induces elevated and persistent functional antibody responses in adults aged 65 > or = yearsSusan B Manoff, Charles Liss, Michael J Caulfield, et al.
Ophthalmology|November 4, 2004
Ocular complications in the Department of Defense Smallpox Vaccination ProgramGary L Fillmore, Thomas P Ward, Kraig S Bower, et al.
Vaccine|November 6, 2007
Smallpox vaccination and ischemic coronary events in healthy adultsRobert E Eckart, Eric A Shry, J Edwin Atwood, et al.
Human Vaccines & Immunotherapeutics|November 15, 2018
Immunogenicity and safety of an investigational tetravalent recombinant subunit vaccine for dengue: results of a Phase I randomized clinical trial in flavivirus-naïve adultsSusan B Manoff, Michele Sausser, Amy Falk Russell, et al.
Vaccine|September 11, 2012
Measles, mumps, and rubella virus vaccine (M-M-R™II): a review of 32 years of clinical and postmarketing experienceFabio Lievano, Susan A Galea, Michele Thornton, et al.
Pageof 6